Journal
BIOLOGICAL CHEMISTRY
Volume 403, Issue 5-6, Pages 455-477Publisher
WALTER DE GRUYTER GMBH
DOI: 10.1515/hsz-2020-0377
Keywords
antibody display; antibody engineering; antibody screening; antibody selection; genotype phenotype coupling
Categories
Funding
- EU project ATAC [101003650]
Ask authors/readers for more resources
Antibody display technologies have enabled the successful isolation of antigen-specific antibodies with therapeutic potential, with genotype-phenotype coupling being a key feature. While phage display is the most established system, newer technologies like mammalian display have also matured in recent years.
Antibody display technologies enable the successful isolation of antigen-specific antibodies with therapeutic potential. The key feature that facilitates the selection of an antibody with prescribed properties is the coupling of the protein variant to its genetic information and is referred to as genotype phenotype coupling. There are several different platform technologies based on prokaryotic organisms as well as strategies employing higher eukaryotes. Among those, phage display is the most established system with more than a dozen of therapeutic antibodies approved for therapy that have been discovered or engineered using this approach. In recent years several other technologies gained a certain level of maturity, most strikingly mammalian display. In this review, we delineate the most important selection systems with respect to antibody generation with an emphasis on recent developments.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available